Chenivesse et al., 2018 - Google Patents
CCL18–Beyond chemotaxisChenivesse et al., 2018
- Document ID
- 17395512977473685241
- Author
- Chenivesse C
- Tsicopoulos A
- Publication year
- Publication venue
- Cytokine
External Links
Snippet
The chemokine CCL18 is constitutively expressed in human lung and serum, and is further elevated during pathologic conditions such as allergy, fibrosis and cancer, suggesting that it may participate in both homeostatic and inflammatory processes. Under steady state …
- 230000035605 chemotaxis 0 title description 5
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2026—IL-4
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chenivesse et al. | CCL18–Beyond chemotaxis | |
| Zrioual et al. | IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR+ CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood | |
| Lazzeri et al. | CXCR3-binding chemokines: novel multifunctional therapeutic targets | |
| Alunno et al. | Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets | |
| Yoshie et al. | CCR4 and its ligands: from bench to bedside | |
| Xia et al. | S100 proteins as an important regulator of macrophage inflammation | |
| Vicari et al. | Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms | |
| Tschopp et al. | Granzyme B, a novel mediator of allergic inflammation: its induction and release in blood basophils and human asthma | |
| Barnes | The cytokine network in asthma and chronic obstructive pulmonary disease | |
| Reinhardt et al. | Monocyte-induced development of Th17 cells and the release of S100 proteins are involved in the pathogenesis of graft-versus-host disease | |
| De Nadai et al. | Involvement of CCL18 in allergic asthma | |
| Fujii | New therapies and immunological findings in cutaneous T-cell lymphoma | |
| Beaty et al. | Diverse and potent chemokine production by lung CD11bhigh dendritic cells in homeostasis and in allergic lung inflammation | |
| Monteleone et al. | Characterization of IL-17A–producing cells in celiac disease mucosa | |
| Wirnsberger et al. | IL‐4 induces expression of TARC/CCL17 via two STAT6 binding sites | |
| Charles et al. | The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans | |
| Kurowska-Stolarska et al. | IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation | |
| Hoge et al. | IL-6 controls the innate immune response against Listeria monocytogenes via classical IL-6 signaling | |
| Gombert et al. | CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation | |
| Ushio et al. | CCL22-producing resident macrophages enhance T cell response in Sjögren's syndrome | |
| Yamanaka et al. | The role of cytokines/chemokines in the pathogenesis of atopic dermatitis | |
| Cassatella et al. | Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators | |
| Feuser et al. | Human intestinal mast cells are a potent source of multiple chemokines | |
| Miyagaki et al. | Increased CCL18 expression in patients with cutaneous T‐cell lymphoma: association with disease severity and prognosis | |
| Nieto-Fontarigo et al. | CD26 and asthma: a comprehensive review |